<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Neurol</journal-id>
      <journal-title-group>
        <journal-title>BMC Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2377</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26329680</article-id>
      <article-id pub-id-type="pmc">4557863</article-id>
      <article-id pub-id-type="publisher-id">415</article-id>
      <article-id pub-id-type="doi">10.1186/s12883-015-0415-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Leukoencephalopathy resolution after atypical mycobacterial treatment: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Marcos C. B.</given-names>
          </name>
          <address>
            <email>marcoscbo@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sato</surname>
            <given-names>Douglas Kazutoshi</given-names>
          </name>
          <address>
            <email>douglas.sato@med.tohoku.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Soares-Neto</surname>
            <given-names>Herval R.</given-names>
          </name>
          <address>
            <email>hervalneto@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lucato</surname>
            <given-names>Leandro T.</given-names>
          </name>
          <address>
            <email>ltlucato@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Callegaro</surname>
            <given-names>Dagoberto</given-names>
          </name>
          <address>
            <email>dgcallegaro@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nitrini</surname>
            <given-names>Ricardo</given-names>
          </name>
          <address>
            <email>rnitrini@uol.com.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Medeiros</surname>
            <given-names>Raphael S. S.</given-names>
          </name>
          <address>
            <email>raphael.salles@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Misu</surname>
            <given-names>Tatsuro</given-names>
          </name>
          <address>
            <email>misu@med.tohoku.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fujihara</surname>
            <given-names>Kazuo</given-names>
          </name>
          <address>
            <email>fujikazu@med.tohoku.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Castro</surname>
            <given-names>Luiz H.</given-names>
          </name>
          <address>
            <phone>+5511994357268</phone>
            <email>castrolh@usp.br</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Neurology, Faculdade de Medicina da Universidade de Sao Paulo, Av. Dr. En&#xE9;as de Carvalho Aguiar, 255, 5o andar, sala 5011, 05403-900 S&#xE3;o Paulo, SP Brazil </aff>
        <aff id="Aff2"><label/>Institute of Radiology, Faculdade de Medicina da Universidade de Sao Paulo, Av. Dr. En&#xE9;as de Carvalho Aguiar, 255, 5o andar, sala 5011, 05403-900 S&#xE3;o Paulo, SP Brazil </aff>
        <aff id="Aff3"><label/>Department of Pathology, Faculdade de Medicina da Universidade de Sao Paulo, Av. Dr. En&#xE9;as de Carvalho Aguiar, 255, 5o andar, sala 5011, 05403-900 S&#xE3;o Paulo, SP Brazil </aff>
        <aff id="Aff4"><label/>Departments of Neurology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575 Japan </aff>
        <aff id="Aff5"><label/>Multiple Sclerosis Therapeutics, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>2</day>
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>2</day>
        <month>9</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>159</elocation-id>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>8</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Oliveira et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Association of leukoencephalopathy and atypical mycobacteriosis has been rarely reported. We present a case that is relevant for its unusual presentation and because it may shed further light on the pathogenic mechanisms underlying reversible encephalopathies.</p>
        </sec>
        <sec>
          <title>Case report</title>
          <p>We report the case of a Hispanic 64-year-old woman with cognitive decline and extensive leukoencephalopathy. Magnetic resonance imaging revealed white-matter lesions with increased water diffusivity, without blood&#x2013;brain-barrier disruption. Brain biopsy showed tissue rarefaction with vacuolation, mild inflammation, few reactive astrocytes and decreased aquaporin water-channel expression in the lesions. Six months later, she was diagnosed with atypical mycobacterial pulmonary infection. Brain lesions resolved after antimycobacterial treatment.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>We hypothesize leukoencephalopathic changes and vasogenic edema were associated with decreased aquaporin expression. Further studies should clarify if reversible leukoencephalopathy has a causal relationship with decreased aquaporin expression and atypical mycobacterial infection, and mechanisms underlying leukoencephalopathy resolution after antimycobacterial treatment. This article may contribute to the understanding of pathogenic mechanisms underlying magnetic resonance imaging subcortical lesions and edema, which remain incompletely understood.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Reversible encephalopathy syndrome</kwd>
        <kwd>PRES</kwd>
        <kwd>Mycobacteriosis</kwd>
        <kwd>Leukoencephalopathy</kwd>
        <kwd>Vasogenic edema</kwd>
        <kwd>Aquaporin water-channel</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Reversible leukoencephalopathy is characterized by headaches, seizures, vomiting, and confusion, associated with extensive bilateral white-matter subcortical neuroimaging abnormalities, suggestive of vasogenic edema without infarction [<xref ref-type="bibr" rid="CR1">1</xref>]. Most cases of reversible encephalopathy are referred to as posterior reversible encephalopathy syndrome (PRES), since white matter changes are more prominent in the posterior cerebral regions. Brainstem, cerebellum and other brain regions may also be affected [<xref ref-type="bibr" rid="CR2">2</xref>]. PRES has been associated with severe hypertension (including eclampsia), renal dysfunction, infection, autoimune disease, and immunosuppressant drug use [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR7">7</xref>]. The hallmark of PRES is reversible cerebral edema due to blood&#x2013;brain-barrier dysfunction [<xref ref-type="bibr" rid="CR8">8</xref>]. Pathogenic mechanisms underlying magnetic resonance imaging (MRI) subcortical lesions and edema remains incompletely understood.</p>
      <p>Association of brain edema and mycobacteria has previously been reported in the setting of <italic>Mycobacterium tuberculosis</italic> infection [<xref ref-type="bibr" rid="CR9">9</xref>&#x2013;<xref ref-type="bibr" rid="CR15">15</xref>], and in one patient who presented with acute disseminated encephalomyelitis (ADEM) associated with <italic>Mycobacterium intracellulare</italic> meningitis, who responded to high dose steroid pulse therapy [<xref ref-type="bibr" rid="CR16">16</xref>]. In all reported cases of mycobacterial infection associated with edema, underlying mechanisms involved demyelination and inflammation. Association of a non-demyelinating leukoencephalopathy and atypical mycobacteriosis has not, to our knowledge, been previously reported.</p>
      <p>We report neuroimaging and brain histology features of a patient with extensive leukoencephalopathy with brain edema and absence of demyelination, that resolved after atypical mycobacterial pulmonary infection treatment.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A Hispanic 64-year-old woman was admitted with headaches, vomiting and confusion. A month earlier, the patient presented with subacute new-onset headaches, nausea, vomiting, gait impairment, and anorexia. There was no history of fever, cough, abdominal pain, previous medical disease or immunosuppressant drug use. Blood pressure was normal. Physical examination was unremarkable. Neurologic examination showed an unsteady gait, without motor weakness or ataxia. Cognitive tests showed a Mini-Mental Status Exam (MMSE) score of 18/30, impaired attention, executive functions, verbal fluency and episodic memory (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Cognitive evaluations in a patient with reversible leukoencephalopathy before and after atypical mycobacteria treatment</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Initial assessment</th><th>Five months after initial assessment (no mycobacterial treatment)</th><th>Eighteen months after initial assessment (one year of mycobaterial treatment)</th></tr></thead><tbody><tr><td>Mini Mental State Exam (MMSE)</td><td>18/30</td><td>18/30</td><td>22/30</td></tr><tr><td>Digit span (direct/indirect)</td><td>3 / 0</td><td>3 / 0</td><td>4 / 2</td></tr><tr><td>Short Memory Test with 10 items (incidental memory / immediate memory / learning)<sup>*</sup>
</td><td>3 / 7 / 8</td><td>4 / 1 / 1</td><td>5 / 7 / 8</td></tr><tr><td>Delayed Memory Test with 10 items (after distraction) without / with hints<sup>*</sup>
</td><td>6 (1) / 8</td><td>3 / 4 (3)</td><td>8 / 10</td></tr><tr><td>Verbal fluency (semantic / phonemic)</td><td>5 (animals) / 1 (letter P)</td><td>6 (animals) / 1 (letter P)</td><td>10 (animals) / 1 (letter P)</td></tr><tr><td>Clock-drawing test</td><td>Disexecutive: distortion of number placement (4 points)</td><td>Disexecutive: crowding numbers to one side (5 points)</td><td>More noticeable errors in hand/number placement (8 points)</td></tr><tr><td>Functional Activity Questionnaire (FAQ)</td><td/><td>25/30</td><td>10/30</td></tr></tbody></table><table-wrap-foot><p>Patient&#x2019;s education: 4 Years</p><p>Legend: <sup>*</sup>Number of intrusions between brackets</p></table-wrap-foot></table-wrap></p>
      <p>Brain MRI disclosed diffuse and symmetric confluent nonenhancing white matter lesions, that were hyperintense in T2/FLAIR images (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref> to <xref rid="Fig1" ref-type="fig">d</xref>). Corresponding apparent diffusion coefficients (ADC) maps suggested vasogenic edema (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1f</xref>). MRI angiography was unremarkable (not shown). Multivoxel spectroscopy, dynamic susceptibility contrast (DSC) perfusion (T2*) and dynamic contrast-enhanced (DCE) permeability (T1) did not disclose relevant abnormalities (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1e, g</xref> and <xref rid="Fig1" ref-type="fig">h</xref>). Cerebrospinal fluid analysis showed a normal cell count (4 cells/mm3), protein (32&#xA0;mg/dL) and glucose (80&#xA0;mg/dL) levels, normal protein electrophoresis values, negative oligoclonal bands and polymerase chain reaction for infectious agents (including tuberculosis). Systemic evaluation was negative for cancer, autoimmune diseases (Anti-nuclear antibodies&#x2009;=&#x2009;negative, Anti-neutrophil cytoplasmic antibodies&#x2009;=&#x2009;negative), and infectious diseases. Thoracic computed tomography (CT) showed nonspecific patchy lung infiltrates. Blood laboratory tests were normal (i.e. Erythrocyte sedimentation rate&#x2009;=&#x2009;2&#xA0;mm; C-reactive protein&#x2009;=&#x2009;1,3&#xA0;mg/L; Leucocytes&#x2009;=&#x2009;6,880/mm3). Electroencephalogram EEG showed mild diffuse slowing and brief bursts of diffuse delta waves. The patient underwent two brain biopsies that showed tissue rarefaction with vacuolation, very mild inflammatory cell and macrophage infiltrates, absence of demyelination, malignant cells or granulomas, and no signs of tissue infarction or hemorrhagic changes (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref> to <xref rid="Fig2" ref-type="fig">j</xref>). Immunostaining showed scarce CD45+ lymphocytes and CD68+ macrophages, without axonal or myelin damage, with few reactive astrocytes and low aquaporin-4 staining in the lesion compared to the normal surrounding areas. Aquaporin-1 staining was also reduced in the lesion, less extensively than aquaporin-4.<fig id="Fig1"><label>Fig. 1</label><caption><p>Serial brain magnetic resonance imaging studies of a patient with reversible leukoencephalopathy. Brain magnetic resonance imaging (MRI). Initial FLAIR images (<bold>a</bold>-<bold>d</bold>) show diffuse symmetrical confluent hyperintensities involving cerebral white matter, extending to the brainstem and cerebellar white matter. Note mass effect evidenced by sulci, fissure and ventricle effacement (more remarkable considering patient&#x2019;s age - 64&#xA0;years old). Corresponding white matter MR spectroscopy (<bold>e</bold>) (multivoxel, TE&#x2009;=&#x2009;135&#xA0;ms) demonstrates no definite metabolic changes. Apparent diffusion coefficients (ADC) map (<bold>f</bold>) demonstrates diffusion facilitation, signaling vasogenic edema. There was no contrast enhancement (not shown) or significant changes appreciated in color maps proportional to relative cerebral blood volume (rCBV) (<bold>g</bold>) obtained from a dynamic susceptibility contrast (DSC) perfusion (T2*) study. Color maps proportional to wash in rate (<bold>h</bold>) obtained from a dynamic contrast-enhanced (DCE) permeability (T1) sequence were also unremarkable. Images F-H are in the same level as D. After treatment for atypical mycobacteriosis, white matter changes disappeared, as shown in (FLAIR) images (<bold>i</bold>-<bold>l</bold>) obtained two years after the initial exam (arrows in J and L point to biopsy sites, partially characterized in these images)</p></caption><graphic xlink:href="12883_2015_415_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Brain biopsy results of a patient with reversible leukoencephalopathy. <bold>a</bold> to <bold>j</bold>: Brain biopsy results of the patient with reversible leukoencephalopathy prior to atypical mycobacteria treatment shows (<bold>a</bold>) mild tissue rarefaction with vacuolation, very sparse perivascular inflammatory infiltrates, and (<bold>b</bold>) no evidence of demyelination. <bold>c</bold>&#x2013;<bold>d</bold> Presence of relatively few glial fibrillary acidic protein (GFAP) positive astrocytes with reduced aquaporin-4 expression in the lesion compared to the surrounding area. Scale bar&#x2009;=&#x2009;100&#xA0;&#x3BC;m. High magnification (400x) on D shows aquaporin-4 on the membrane of reactive astrocytes. Scale bar&#x2009;=&#x2009;10&#xA0;&#x3BC;m. <bold>e</bold> Aquaporin-1 expression is also reduced in the lesion, but in less extensively than aquaporin-4. <bold>f</bold>&#x2013;<bold>g</bold> Myelin sheath is preserved with no loss of myelin basic protein (MBP) and myelin associated glycoprotein (MAG). <bold>h</bold> No signs of neuronal or axonal damage. <bold>i</bold>&#x2013;<bold>j</bold> Few lymphocytes (CD45+) and macrophages (CD68+) are found in the perivascular space, while immunoglobulin and complement C9neo deposition are absent (not shown). Scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m. (Magnification <bold>a</bold>&#x2013;<bold>d</bold>&#x2009;=&#x2009;100x; <bold>e</bold>&#x2013;<bold>j</bold>&#x2009;=&#x2009;200x)</p></caption><graphic xlink:href="12883_2015_415_Fig2_HTML" id="MO2"/></fig></p>
      <p>The patient was treated initially with intravenous methylprednisolone (1&#xA0;g/day for three days), followed by oral dexamethasone (10&#xA0;mg/day) for six months. Clinical and neurologic status and brain MRI remained unchanged. Activities of daily living were impaired, with a Functional Activity Questionnaire (FAQ) score of 25 and MMSE score of 18. Whole body positron emission tomography-computed tomography obtained at this point revealed a hypermetabolic right pulmonary mass. Lesion histology showed granulomas containing <italic>Mycobacterium abscessus</italic>. The patient was treated with levofloxacin, clarithromycin and amycacin. Steroids were tapered and discontinued. A year later, cognitive functions and functional status were improved (MMSE&#x2009;=&#x2009;21; FAQ score&#x2009;=&#x2009;10) (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>), and brain MRI disclosed remarkable resolution of white matter changes (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1i&#x2013;l</xref>).</p>
    </sec>
    <sec id="Sec3" sec-type="conclusion">
      <title>Conclusions</title>
      <p>This report illustrates a case of leukoencephalopathy associated with atypical pulmonary mycobacteriosis. Although we cannot establish a cause-effect relationship of atypical mycobacteriosis and leukoencephalopathy, lack of central nervous system (CNS) granulomas and caseous necrosis, lack neurological worsening following steroid therapy, and improvement after antimycobacterial treatment suggest a remote effect of the lung infection, causing the CNS disorder.</p>
      <p>Initial chest CT had initially shown nonspecific patchy lung infiltrates, that could, retrospectively, indicate early stage atypical mycobacterial infection. Additionally, the patient presented remarkable, albeit partial, neurological improvement after antimycobacterial treatment. There was no response to steroid therapy, brain pathology studies did not disclose inflammatory activity, and there was absence of intra-thecal antibody production, rendering the possibility of an adaptative immune mechanism (i.e. antibody or cell-mediated immune responses) extremely unlikely. Steroid therapy may have contributed to worsening of the mycobacterial lung infection.</p>
      <p>Mycobacteria are known to be highly immunogenic: mycobacteria containing compounds are used in mouse models of ADEM and Multiple Sclerosis, through activation of adaptative immunity [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Mycobacteria also activate the innate immune system, with production of cytokines and inflammation mediators, such as nitric oxide [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
      <p>Mechanism of brain involvement in this case can be inferred from imaging and pathology findings of tissue edema with scarce reactive astrocytes, and reduced aquaporin-4 and aquaporin-1 expression in the lesion, compared to surrounding areas. Considering the lack of evidence of adaptative immune response in the brain, we speculate that activation of an innate-immune response in the lung either by the mycobacteria or through a host mediated response may have exerted a remote effect on aquaporin expression in the brain, leading to interstitial white matter edema. Alternatively, but less likely, antimycobacterial agents may have exerted a direct action reverting white matter lesions [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
      <p>Few studies have evaluated pathological findings in reversible encephalopathies [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], and some studies suggest the pathogenic role of cellular channel dysfunction. Reversible leukoencephalopathy has been described in few anti-aquaporin-4 antibody positive neuromyelitis optica (NMO) cases following immunotherapeutic interventions [<xref ref-type="bibr" rid="CR3">3</xref>]. Lesion reversibility in these cases suggests that immune-mediated tissue destruction associated with blood&#x2013;brain barrier (BBB) disruption may not be the main underlying mechanism.</p>
      <p>It is conceivable that vasogenic edema noted on diffusion-weighted MRI sequences in reversible leukoencephalopathy cases represents parenchymal excess water content, caused by impaired water influx control, independent from BBB disruption. In our case, water influx control was probably impaired due to astrocyte aquaporin dysfunction, in a mechanism akin to that hypothesized in brain edema associated with NMO [<xref ref-type="bibr" rid="CR3">3</xref>]. Additionally, experimentally induced acute hypertension in rabbits led to exogenous markers leakage in arterioles and capillaries through channels (often sigmoid-shaped) and cytoplasm and by transendothelial pinocytosis, causing brain-barrier disruption and edema [<xref ref-type="bibr" rid="CR22">22</xref>]. These findings suggest impaired water channel function as a possible mechanism underlying reversible leukoencephalopathy.</p>
      <p>We are not aware of previous non-demyelinating reversible leukoencephalopathy cases that improved after atypical mycobacteriosis treatment. We found vacuolated white matter lesions with paucity of reactive astrogliosis and decreased aquaporin water-channel expression. A causal relationship between mycobacteriosis and interstitial edema remains speculative. Alternatively, unexpected drug effects may have contributed to brain changes resolution. Elucidating pathogenic mechanisms underlying reversible leukoencephalopathies may lead to improved therapeutic strategies to treat this condition.</p>
      <sec id="Sec4">
        <title>Consent</title>
        <p>Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
      </sec>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ADEM</term>
          <def>
            <p>Acute disseminated encephalomyelitis</p>
          </def>
        </def-item>
        <def-item>
          <term>ADC</term>
          <def>
            <p>Apparent diffusion coefficients</p>
          </def>
        </def-item>
        <def-item>
          <term>BBB</term>
          <def>
            <p>Blood&#x2013;brain barrier</p>
          </def>
        </def-item>
        <def-item>
          <term>CNS</term>
          <def>
            <p>Central nervous system</p>
          </def>
        </def-item>
        <def-item>
          <term>CT</term>
          <def>
            <p>Computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>DCE</term>
          <def>
            <p>Dynamic contrast-enhanced</p>
          </def>
        </def-item>
        <def-item>
          <term>DSC</term>
          <def>
            <p>Dynamic susceptibility contrast</p>
          </def>
        </def-item>
        <def-item>
          <term>FLAIR</term>
          <def>
            <p>Fluid attenuation inversion recovery</p>
          </def>
        </def-item>
        <def-item>
          <term>FAQ</term>
          <def>
            <p>Functional Activity Questionnaire</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>Magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>MMSE</term>
          <def>
            <p>Mini-Mental Status Exam</p>
          </def>
        </def-item>
        <def-item>
          <term>NMO</term>
          <def>
            <p>Neuromyelitis optica</p>
          </def>
        </def-item>
        <def-item>
          <term>PRES</term>
          <def>
            <p>Posterior reversible encephalopathy syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term>rCBV</term>
          <def>
            <p>Relative cerebral blood volume</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>
<bold>Dr. Oliveira</bold> has no conflicts of interest to disclose. <bold>Dr. Castro</bold> has no conflicts of interest to disclose. <bold>Dr. Sato</bold> is an associated editor of the Arquivos de Neuropsiquiatria (official journal of the Brazilian Academy of Neurology), receives scholarship from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, has received research support from Ichiro Kanehara Foundation (2011), and speaker honorarium from Novartis. <bold>Dr. Soares-Neto</bold> has no conflicts of interest to disclose. <bold>Dr. Lucato</bold> has no conflicts of interest to disclose. <bold>Dr. Callegaro</bold> has no conflicts of interest to disclose. <bold>Dr. Medeiros</bold> has no conflicts of interest to disclose. <bold>Prof. Misu</bold> has received speaker honoraria from Bayer Schering Pharma, Biogen Idec Japan, Mitsubishi Tanabe Pharma Corporation, Asahi Kasei Medical Co., and Astellas Pharma Inc. and has received research support from Bayer Schering Pharma, Biogen Idec Japan, Asahi Kasei Kuraray Medical Co., The Chemo-Sero-Therapeutic Research Institute, Teva Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation, Teijin Pharma, and Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Technology, and the Ministry of Health, Labor and Welfare of Japan. <bold>Prof. Fujihara</bold> serves on scientific advisory boards for Bayer Schering Pharma, Biogen Idec, Mitsubishi Tanabe Pharma Corporation, Novartis Pharma, Chugai Pharmaceutical, Ono Pharmaceutical, Nihon Pharmaceutical, Merck Serono, Alexion Pharmaceuticals, Medimmune and Medical Review; has received funding for travel and speaker honoraria from Bayer Schering Pharma, Biogen Idec, Eisai Inc., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co., Daiichi Sankyo, and Nihon Pharmaceutical; serve as an editorial board member of Clinical and Experimental Neuroimmunology (2009-present) and a advisory board member of Sri Lanka journal of Neurology; has received research support from Bayer Schering Pharma, Biogen Idec Japan, Asahi Kasei Medical, The Chemo-Sero-Therapeutic Research Institute, Teva Pharmaceutical, Mitsubishi Tanabe Pharma, Teijin Pharma, Chugai Pharmaceutical, Ono Pharmaceutical, Nihon Pharmaceutical, and Genzyme Japan; is funded as the secondary investigator (#22229008, 2010&#x2013;2015) by the Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Technology of Japan and as the secondary investigator by the Grants-in-Aid for Scientific Research from the Ministry of Health, Welfare and Labor of Japan (2010-present). <bold>Prof. Nitrini</bold> has no conflicts of interest to disclose.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>MCBO&#x2009;=&#x2009;conception and study design, data analysis and drafting the manuscript; LHMC&#x2009;=&#x2009;study design, data analysis, and drafting the manuscript; DKS&#x2009;=&#x2009;study conception, data analysis and drafting the manuscript; HRSN&#x2009;=&#x2009;data analysis, and drafting the manuscript; LTL&#x2009;=&#x2009;data analysis and review of the manuscript; DC&#x2009;=&#x2009;conception of the study, data analysis and review of the manuscript; RSSM&#x2009;=&#x2009;data analysis and review of the manuscript; TM&#x2009;=&#x2009;design of the study, data analysis, and drafting the manuscript; KF&#x2009;=&#x2009;study conception, data analysis and review of the manuscript; RN&#x2009;=&#x2009;study conception, data analysis and review of the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>This study was partially supported by KAKENHI (22229008) of The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and by the Health and Labor Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labor and Welfare of Japan. The funding sources had no role in the design, collection, analysis, or interpretation of the study, nor in the writing of the article or decision to submit.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hinchey</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chaves</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Appignani</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Breen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A reversible posterior leukoencephalopathy syndrome</article-title>
          <source>N Engl J Med</source>
          <year>1996</year>
          <volume>334</volume>
          <fpage>494</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJM199602223340803</pub-id>
          <pub-id pub-id-type="pmid">8559202</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>VH</given-names>
            </name>
            <name>
              <surname>Wijdicks</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Manno</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Rabinstein</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>Clinical spectrum of reversible posterior leukoencephalopathy syndrome</article-title>
          <source>Arch Neurol</source>
          <year>2008</year>
          <volume>65</volume>
          <fpage>205</fpage>
          <lpage>210</lpage>
          <pub-id pub-id-type="pmid">18268188</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maga&#xF1;a</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Matiello</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pittock</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>McKeon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lennon</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Rabinstein</surname>
              <given-names>AA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders</article-title>
          <source>Neurology</source>
          <year>2009</year>
          <volume>72</volume>
          <issue>8</issue>
          <fpage>712</fpage>
          <lpage>717</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000343001.36493.ae</pub-id>
          <pub-id pub-id-type="pmid">19237699</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>IB</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Boey</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>PH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma</article-title>
          <source>Rheumatology</source>
          <year>2008</year>
          <volume>47</volume>
          <fpage>256</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="doi">10.1093/rheumatology/kem319</pub-id>
          <pub-id pub-id-type="pmid">18084001</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bartynski</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Boardman</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Zeigler</surname>
              <given-names>ZR</given-names>
            </name>
            <name>
              <surname>Shadduck</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Lister</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Posterior reversible encephalopathy syndrome in infection, sepsis, and shock</article-title>
          <source>AJNR Am J Neuroradiol</source>
          <year>2006</year>
          <volume>27</volume>
          <fpage>2179</fpage>
          <lpage>2190</lpage>
          <pub-id pub-id-type="pmid">17110690</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="other">Guerriero S, Ciraci L, Centoducati T, Pignatelli F, Lamargese V, Salvati A, et al. Bilateral Visual Loss as Presenting Symptom of Posterior Reversible Encephalopathy Syndrome in a Patient with HIV/Tuberculosis Coinfection: A Case Report. Case Rep Ophthalmol Med. 2012; doi: 10.1155/2012/850176</mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Viehman</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Khalil</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Barhoma</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Mycobacterium avium-intracellulare otomastoiditis in a young AIDS patient: case report and review of the literature</article-title>
          <source>Hiv/Aids</source>
          <year>2013</year>
          <volume>5</volume>
          <fpage>61</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">23459156</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feske</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Posterior reversible encephalopathy syndrome: a review</article-title>
          <source>Semin Neurol</source>
          <year>2011</year>
          <volume>31</volume>
          <fpage>202</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="doi">10.1055/s-0031-1277990</pub-id>
          <pub-id pub-id-type="pmid">21590625</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dastur</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Udani</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>The pathology and pathogenesis of tuberculous encephalopathy</article-title>
          <source>Acta Neuropathol</source>
          <year>1966</year>
          <volume>6</volume>
          <fpage>311</fpage>
          <lpage>326</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00688161</pub-id>
          <pub-id pub-id-type="pmid">5297864</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dastur</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
          <article-title>The pathology and pathogenesis of tuberculous encephalopathy and myeloradiculopathy: a comparison with allergic encephalomyelitis</article-title>
          <source>Childs Nerv Syst</source>
          <year>1986</year>
          <volume>2</volume>
          <fpage>13</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00274027</pub-id>
          <pub-id pub-id-type="pmid">3731158</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Udani</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Dastur</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
          <article-title>Tuberculous encephalopathy with and without meningitis. Clinical features and pathological correlations</article-title>
          <source>J Neurol Sci</source>
          <year>1970</year>
          <volume>10</volume>
          <fpage>541</fpage>
          <lpage>561</lpage>
          <pub-id pub-id-type="doi">10.1016/0022-510X(70)90187-5</pub-id>
          <pub-id pub-id-type="pmid">5422557</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lammie</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Hewlett</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Schoeman</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Donald</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Tuberculous encephalopathy: a reappraisal</article-title>
          <source>Acta Neuropathol</source>
          <year>2007</year>
          <volume>113</volume>
          <issue>3</issue>
          <fpage>227</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="doi">10.1007/s00401-006-0172-7</pub-id>
          <pub-id pub-id-type="pmid">17171342</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Shim</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>EY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tuberculous encephalopathy without meningitis: pathology and brain MRI findings</article-title>
          <source>Eur Neurol</source>
          <year>2011</year>
          <volume>65</volume>
          <issue>3</issue>
          <fpage>156</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1159/000324170</pub-id>
          <pub-id pub-id-type="pmid">21372574</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Char</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>OS</given-names>
            </name>
          </person-group>
          <article-title>Tuberculous encephalopathy. A rare complication of pulmonary tuberculosis</article-title>
          <source>West Indian Med J</source>
          <year>2000</year>
          <volume>49</volume>
          <issue>1</issue>
          <fpage>70</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">10786460</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chetty</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Mahutte</surname>
              <given-names>CK</given-names>
            </name>
          </person-group>
          <article-title>Acute hemorrhagic leukoencephalitis during treatment for disseminated tuberculosis in a patient with AIDS</article-title>
          <source>Int J Tuberc Lung Dis</source>
          <year>1997</year>
          <volume>1</volume>
          <issue>6</issue>
          <fpage>579</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">9487459</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshioka</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Acute Disseminated Encephalomyelitis Associated with Meningitis due to Mycobacterium intracellulare</article-title>
          <source>Inter Med</source>
          <year>2010</year>
          <volume>49</volume>
          <fpage>2113</fpage>
          <lpage>2116</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.49.3323</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolf</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Amouzegar</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Swanborg</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Synergistic interaction between Toll-like receptor agonists is required for induction of experimental autoimmune encephalomyelitis in Lewis rats</article-title>
          <source>J Neuroimmunol</source>
          <year>2007</year>
          <volume>185</volume>
          <issue>1&#x2013;2</issue>
          <fpage>115</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jneuroim.2007.02.001</pub-id>
          <pub-id pub-id-type="pmid">17341432</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zorzella-Pezavento</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Guerino</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Chiuso-Minicucci</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fran&#xE7;a</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Ishikawa</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Masson</surname>
              <given-names>AP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental Autoimmune Encephalomyelitis</article-title>
          <source>Clin Dev Immunol</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>721383</fpage>
          <pub-id pub-id-type="doi">10.1155/2013/721383</pub-id>
          <pub-id pub-id-type="pmid">24288555</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sandor</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Heninger</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fabry</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Mycobacteria-induced suppression of autoimmunity in the central nervous system</article-title>
          <source>J Neuroimmune Pharmacol</source>
          <year>2010</year>
          <volume>5</volume>
          <issue>2</issue>
          <fpage>210</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1007/s11481-010-9199-6</pub-id>
          <pub-id pub-id-type="pmid">20333556</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dalhoff</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shalit</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Immunomodulatory effects of quinolones</article-title>
          <source>Lancet Infect Dis</source>
          <year>2003</year>
          <volume>3</volume>
          <fpage>359</fpage>
          <lpage>371</lpage>
          <pub-id pub-id-type="doi">10.1016/S1473-3099(03)00658-3</pub-id>
          <pub-id pub-id-type="pmid">12781508</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chester</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Agamanolis</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Banker</surname>
              <given-names>BQ</given-names>
            </name>
            <name>
              <surname>Victor</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Hypertensive encephalopathy: a clinicopathologic study of 20 cases</article-title>
          <source>Neurology</source>
          <year>1978</year>
          <volume>28</volume>
          <fpage>928</fpage>
          <lpage>939</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.28.9.928</pub-id>
          <pub-id pub-id-type="pmid">567764</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hansson</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Johansson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Blomstrand</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Ultrastructural studies on cerebrovascular permeability in acute hypertension</article-title>
          <source>Acta Neuropathol</source>
          <year>1975</year>
          <volume>32</volume>
          <fpage>187</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00696568</pub-id>
          <pub-id pub-id-type="pmid">1180001</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
